CXCL8 and COVID-19: Elevated levels of NETs, neutrophilia, high neutrophil-to-lymphocyte ratio (NLR), neutrophil activators (CXCL8/IL-8 and granulocyte colony-stimulating factor), and effectors (resistin, the IL-8-inducer lipocalin-2, and hepatocyte growth factor) have been reported as indicators of severe respiratory disease and poor outcomes in COVID-19 patients (14–20).